Pharmacokinetic profile of cefoperazone in healthy volunteers C. M. WarnsH. LodeT. Jendroschek Clinical Pharmacology Pages: S13 - S16
Clinical implications of the microbiological and pharmacokinetic properties of cefoperazone J. F. AcarM. D. Kitzis Clinical Pharmacology Pages: S17 - S23
The pharmacokinetics of cefoperazone in normal and impaired renal function D. HöfflerC. PiperP. Koeppe Clinical Pharmacology Pages: S24 - S29
Effect of cefoperazone alone and in combination with tobramycin on the proximal tubular membrane of the human kidney A. W. Mondorf Clinical Pharmacology Pages: S30 - S33
Pharmacokinetics and biliary excretion of cefoperazone in patients with bile duct drainage M. C. MartiC. FarquetM. Rudhardt Clinical Pharmacology Pages: S34 - S36
Serum levels and urinary excretion of cefoperazone in patients with hepatic insufficiency B. CochetJ. BelaieffM. Rudhardt Clinical Pharmacology Pages: S37 - S39
Cefoperazone in complicated urinary tract infections J. ZanggerM. TauferK. Kratochvil Clinical Studies Pages: S40 - S43
Cefoperazone in the treatment of lower respiratory tract infections J. MoserB. Morell Clinical Studies Pages: S44 - S49
Clinical evaluation of cefoperazone in internal medicine A. BertoyeF. DestaingF. Wattel Clinical Studies Pages: S50 - S53
Cefoperazone in abdominal and soft tissue infections R. Chlebusch-von der Heyden Clinical Studies Pages: S54 - S57
The treatment of gram-negative bacillary septicemia with cefoperazone H. LagastJ. Klastersky Clinical Studies Pages: S58 - S60